Literature DB >> 17093065

Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease.

Martin Flamant1, Sandrine Placier, Anita Rodenas, Cyrile Anne Curat, Wolfgang F Vogel, Christos Chatziantoniou, Jean-Claude Dussaule.   

Abstract

A frequent complication of hypertension is the development of chronic renal failure. This pathology usually is initiated by inflammatory events and is characterized by the abnormal accumulation of collagens within the renal tissue. The purpose of this study was to investigate the role of discoidin domain receptor 1 (DDR1), a nonintegrin collagen receptor that displays tyrosine-kinase activity, in the development of renal fibrosis. To this end, hypertension was induced with angiotensin in mice that were genetically deficient of DDR1 and in wild-type controls. After 4 or 6 wk of angiotensin II administration, wild-type mice developed hypertension that was associated with perivascular inflammation, glomerular sclerosis, and proteinuria. Systolic pressure increase was similar in the DDR1-deficient mice, but the histologic lesions of glomerular fibrosis and inflammation were significantly blunted and proteinuria was markedly prevented. Immunostaining for lymphocytes, macrophages, and collagens I and IV was prominent in the renal cortex of wild-type mice but substantially reduced in DDR1 null mice. In separate experiments, renal cortical slices of DDR1 null mice showed a blunted response of chemokines to LPS that was accompanied by a considerable protection against the LPS-induced mortality. These results indicate the importance of DDR1 in mediating inflammation and fibrosis. Use of DDR1 inhibitors could provide a completely novel therapeutic approach against diseases that have these combined pathologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093065     DOI: 10.1681/ASN.2006060677

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

Review 1.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

Review 2.  Matrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approaches.

Authors:  G Dimas; F Iliadis; D Grekas
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

3.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 4.  Discoidin domain receptor-1 and periostin: new players in chronic kidney disease.

Authors:  Carlo Alfieri; Panagiotis Kavvadas; Paola Simonini; Masami Ikehata; Jean Claude Dussaule; Christos E Chadjichristos; Maria Pia Rastaldi; Piergiorgio Messa; Christos Chatziantoniou
Journal:  Nephrol Dial Transplant       Date:  2015-03-31       Impact factor: 5.992

5.  Novel Targets for Therapy of Renal Fibrosis.

Authors:  Niki Prakoura; Juliette Hadchouel; Christos Chatziantoniou
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

6.  Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.

Authors:  Dominique Guerrot; Monique Kerroch; Sandrine Placier; Sophie Vandermeersch; Claire Trivin; Mouna Mael-Ainin; Christos Chatziantoniou; Jean-Claude Dussaule
Journal:  Am J Pathol       Date:  2011-05-13       Impact factor: 4.307

Review 7.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

Review 8.  Cell Receptor-Basement Membrane Interactions in Health and Disease: A Kidney-Centric View.

Authors:  Corina M Borza; Xiwu Chen; Roy Zent; Ambra Pozzi
Journal:  Curr Top Membr       Date:  2015       Impact factor: 3.049

9.  Leptin receptor interacts with rat chromosome 1 to regulate renal disease traits.

Authors:  Craig H Warden; Rodrigo Gularte-Mérida; Janis S Fisler; Susan Hansen; Noreene Shibata; Anh Le; Juan F Medrano; Judith S Stern
Journal:  Physiol Genomics       Date:  2012-09-11       Impact factor: 3.107

10.  Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin.

Authors:  Anne-Cécile Huby; Maria-Pia Rastaldi; Kathleen Caron; Oliver Smithies; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.